Vicapsys Life Sciences, Inc. (VICP)
0.65
+0.14
(+27.45%)
USD |
OTCM |
Oct 02, 16:00
Vicapsys Life Sciences EPS Diluted (Quarterly) : -0.003 for March 31, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.003 |
| March 31, 2025 | -0.0051 |
| December 31, 2024 | -0.0073 |
| September 30, 2024 | -0.0069 |
| June 30, 2024 | -0.0056 |
| March 31, 2024 | -0.0102 |
| December 31, 2023 | -0.0186 |
| September 30, 2023 | -0.007 |
| June 30, 2023 | -0.0038 |
| March 31, 2023 | -0.0061 |
| December 31, 2022 | -0.0158 |
| September 30, 2022 | -0.0048 |
| June 30, 2022 | -0.0058 |
| March 31, 2022 | -0.0058 |
| Date | Value |
|---|---|
| December 31, 2021 | -0.0058 |
| September 30, 2021 | -0.0064 |
| June 30, 2021 | -0.0041 |
| March 31, 2021 | 0.0016 |
| December 31, 2020 | -0.0044 |
| September 30, 2020 | -0.0051 |
| June 30, 2020 | -0.0132 |
| March 31, 2020 | -0.0208 |
| December 31, 2019 | -0.0143 |
| June 30, 2019 | -0.0247 |
| December 31, 2018 | -0.1038 |
| March 31, 2010 | -1.90 |
| March 31, 2009 | -0.90 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.1046M |
| Total Expenses (Quarterly) | 0.1046M |
| Enterprise Value | 21.53M |
| Earnings Yield | -3.43% |
| Normalized Earnings Yield | -3.431 |